Northwest & Ethical Investments’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.5M | Sell |
210,858
-13,145
| -6% | -$1.06M | 0.38% | 79 |
|
|
2026
Q1 | $19.4M | Buy |
224,003
+36,691
| +20% | +$3.51M | 0.45% | 71 |
|
|
2025
Q4 | $18M | Buy |
187,312
+151,600
| +425% | +$14.7M | 0.4% | 74 |
|
|
2025
Q3 | $3.4M | Hold |
35,712
| – | – | 0.08% | 219 |
|
|
2025
Q2 | $3.11M | Buy |
35,712
+1,920
| +6% | +$163K | 0.08% | 219 |
|
|
2025
Q1 | $3.04M | Buy |
33,792
+11,070
| +49% | +$991K | 0.08% | 217 |
|
|
2024
Q4 | $1.82M | Buy |
22,722
+1,371
| +6% | +$119K | 0.05% | 259 |
|
|
2024
Q3 | $1.92M | Hold |
21,351
| – | – | 0.05% | 254 |
|
|
2024
Q2 | $1.68M | Buy |
21,351
+8,912
| +72% | +$731K | 0.05% | 258 |
|
|
2024
Q1 | $1.08M | Buy |
+12,439
| New | +$1.06M | 0.03% | 293 |
|
|
2022
Q3 | – | Sell |
-1,887
| Closed | -$169K | – | 420 |
|
|
2022
Q2 | $169K | Sell |
1,887
-129
| -6% | -$13.1K | 0.01% | 386 |
|
|
2022
Q1 | $224K | Sell |
2,016
-7,388
| -79% | -$781K | 0.01% | 381 |
|
|
2021
Q4 | $973K | Sell |
9,404
-3,850
| -29% | -$446K | 0.03% | 307 |
|
|
2021
Q3 | $1.66M | Sell |
13,254
-122
| -0.9% | -$15.8K | 0.05% | 242 |
|
|
2021
Q2 | $1.66M | Sell |
13,376
-31,548
| -70% | -$3.96M | 0.05% | 255 |
|
|
2021
Q1 | $5.31M | Sell |
44,924
-2,189
| -5% | -$257K | 0.19% | 156 |
|
|
2020
Q4 | $5.52M | Buy |
47,113
+3,101
| +7% | +$341K | 0.21% | 139 |
|
|
2020
Q3 | $4.57M | Buy |
44,012
+1,598
| +4% | +$160K | 0.2% | 141 |
|
|
2020
Q2 | $3.89M | Buy |
42,414
+10,828
| +34% | +$1.04M | 0.18% | 150 |
|
|
2020
Q1 | $2.85M | Buy |
31,586
+12,077
| +62% | +$1.28M | 0.17% | 171 |
|
|
2019
Q4 | $2.21M | Buy |
19,509
+295
| +2% | +$32.4K | 0.1% | 252 |
|
|
2019
Q3 | $2.09M | Buy |
19,214
+411
| +2% | +$42.9K | 0.1% | 243 |
|
|
2019
Q2 | $1.83M | Buy |
18,803
+4,015
| +27% | +$367K | 0.09% | 268 |
|
|
2019
Q1 | $1.35M | Buy |
14,788
+451
| +3% | +$40.4K | 0.07% | 296 |
|
|
2018
Q4 | $1.3M | Buy |
14,337
+13,437
| +1,493% | +$1.26M | 0.08% | 285 |
|
|
2018
Q3 | $88.5K | Sell |
900
-1,300
| -59% | -$120K | 0.01% | 333 |
|
|
2018
Q2 | $188K | Buy |
2,200
+300
| +16% | +$25.1K | 0.01% | 321 |
|
|
2018
Q1 | $152K | Hold |
1,900
| – | – | 0.01% | 330 |
|
|
2017
Q4 | $153K | Buy |
+1,900
| New | +$152K | 0.01% | 320 |
|
|
2017
Q3 | – | Sell |
-10,273
| Closed | -$912K | – | 366 |
|
|
2017
Q2 | $912K | Buy |
10,273
+9,200
| +857% | +$776K | 0.06% | 290 |
|
|
2017
Q1 | $86.4K | Hold |
1,073
| – | – | 0.01% | 357 |
|
|
2016
Q4 | $76.4K | Buy |
+1,073
| New | +$84.3K | 0.01% | 362 |
|
|
2014
Q3 | – | Sell |
-67,100
| Closed | -$4.28M | – | 225 |
|
|
2014
Q2 | $4.28M | Buy |
+67,100
| New | +$4.08M | 0.27% | 91 |
|
|
2013
Q4 | – | Sell |
-32,570
| Closed | -$1.73M | – | 237 |
|
|
2013
Q3 | $1.73M | Sell |
32,570
-4,205
| -11% | -$226K | 0.13% | 163 |
|
|
2013
Q2 | $1.89M | Buy |
+36,775
| New | +$1.82M | 0.15% | 133 |
|
Other funds holding MDT
Northwest & Ethical Investments's MDT Position: Q2 2026 in Review
Northwest & Ethical Investments reduced its Medtronic (MDT) stake by 5.9% in Q2 2026, selling an estimated $1.06M and leaving 210,858 shares worth $16.5M. The position accounts for 0.38% of the portfolio, ranked #79.
Northwest & Ethical Investments first reported a position in MDT in Q2 2013 and has held it in 35 quarters since. The position peaked at $19.4M in Q1 2026. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Northwest & Ethical Investments held 210,858 shares of Medtronic worth $16.5M as of Q2 2026.
- Northwest & Ethical Investments sold 13,145 Medtronic shares in Q2 2026, an estimated $1.06M.
- Medtronic made up 0.38% of Northwest & Ethical Investments's portfolio in Q2 2026, its #79 holding.
- Northwest & Ethical Investments first reported a position in Medtronic in Q2 2013 and has held it in 35 quarters since.
- Northwest & Ethical Investments's Medtronic position peaked at $19.4M in Q1 2026.
- 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.